Lv2
160 积分 2021-01-04 加入
Targeting cancer with small molecule pan-KRAS degraders
17天前
已完结
TCR Pathway Mutations in Mature T Cell Lymphomas
26天前
已完结
Advances in the design of ITK inhibitors
28天前
已完结
Update on T-Cell Lymphoma Epidemiology
1个月前
已完结
Design of novel FN3 domains with high stability by a consensus sequence approach
1个月前
已完结
BL-B01D1, a first-in-class EGFR–HER3 bispecific antibody–drug conjugate, in patients with locally advanced or metastatic solid tumours: a first-in-human, open-label, multicentre, phase 1 study
1个月前
已完结
BL-B01D1, a first-in-class EGFR–HER3 bispecific antibody–drug conjugate, in patients with locally advanced or metastatic solid tumours: a first-in-human, open-label, multicentre, phase 1 study
1个月前
已完结
Ivonescimab Plus Chemotherapy in Non–Small Cell Lung Cancer With EGFR Variant
1个月前
已完结
Trastuzumab deruxtecan in patients with metastatic non-small-cell lung cancer (DESTINY-Lung01): primary results of the HER2-overexpressing cohorts from a single-arm, phase 2 trial
2个月前
已完结
HER2-low expression in patients with advanced or metastatic solid tumors
2个月前
已完结
皖公网安备34019202002308
